ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
24 hedge funds and large institutions have $5.94M invested in Acura Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
17% less capital invested
Capital invested by funds: $7.14M → $5.94M (-$1.2M)
Holders
24
Holding in Top 10
1
Calls
$47K
Puts
–
Top Buyers
| 1 | +$49K | |
| 2 | +$10.2K | |
| 3 | +$10.1K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$711 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$33 |
Top Sellers
| 1 | -$265K | |
| 2 | -$38K | |
| 3 | -$9.42K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.03K |
| 5 |
Morgan Stanley
New York
|
-$31 |